Correlating Raman Spectroscopy with Digital Images of Contrast Enhanced Tissue

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The application of spectroscopic measurements to tissue analysis is limited by the inability to correlate spectroscopic data with histopathology evident in image data, due to interference from traditional contrasting agents.

Innovation Solution

A method that involves obtaining spectroscopic data sets for tissue samples before and after treatment with a contrast enhancing agent, storing positional information to reposition the sample, and linking digital images with spectroscopic data sets using a mathematical transformation to map spatial coordinates, enabling the classification of disease states by searching a database of known samples.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional contrasting agents are used to enhance histopathology visibility in tissue samples, then image data quality is improved, but the ability to correlate spectroscopic data with histopathology is lost due to interference

Engineering Contradiction:
Improvehistopathology visibilityVSAvoidspectroscopic data correlation
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The patent segments the analysis process into distinct phases: acquiring spectroscopic data from untreated tissue, then separately acquiring enhanced images after contrast agent application. By separating these measurements in time and using positional tracking, the patent allows each method to operate optimally without mutual interference, resolving the contradiction between image enhancement and spectroscopic data integrity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces positional information and transformation algorithms as intermediaries that bridge the spectroscopic data and enhanced images. These intermediaries enable correlation between the two data types without requiring simultaneous presence of both spectroscopic measurements and contrast agents, thus maintaining both image quality and spectroscopic data validity

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If spectroscopic measurements are taken before contrast enhancement, then spectroscopic data integrity is maintained, but correlation with histopathology is difficult due to positional differences

Engineering Contradiction:
Improvespectroscopic data integrityVSAvoidpositional alignment
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent performs preliminary acquisition of spectroscopic data from untreated tissue before applying contrast agents. By capturing this data first, the patent ensures spectroscopic integrity is maintained. Subsequently, positional information is recorded and used to align with post-enhancement images, resolving the positional alignment challenge through advance preparation

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent implements a feedback mechanism where positional information from the spectroscopic measurement phase is used to guide the alignment process in the image analysis phase. Transformation algorithms use this feedback to correct positional discrepancies and accurately map spectroscopic data to corresponding regions in enhanced images

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS7701573B2Method for correlating spectroscopic measurements with digital images of contrast enhanced tissue
Publication Date: 2010.04.20 CHEMIMAGE CORP
  • US7701573B2 patent drawing
  • US7701573B2 patent drawing
  • US7701573B2 patent drawing

AI summary

A system and method of correlating Raman measurements with digital images of a sample so as to classify the sample's disease state. A spectroscopic data set is obtained for the sample positioned in the field of view of a spectroscopic device. With the sample removed from the field of view, the sample is treated with a contrast enhancing agent. The treated sample is repositioned in the spectroscopic device's field of view and a digital image of the treated sample is obtained. The spectroscopic data set is linked with the digital image by defining a transformation to map the image spatial coordinates of the digital image to the spectral spatial coordinates of the spectroscopic data. For the spectroscopic data set of the sample, the database is searched to identify a spectroscopic data set, of a known sample having well characterized pathology, which matches the sample's spectroscopic data set.